11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This ISPOR Good Practices report provides a framework for assessing the suitability of electronic health records data for use in health technology assessments (HTAs). Although electronic health record (EHR) data can fill evidence gaps and improve decisions, several important limitations can affect its validity and relevance. The ISPOR framework includes 2 components: data delineation and data fitness for purpose. Data delineation provides a complete understanding of the data and an assessment of its trustworthiness by describing (1) data characteristics; (2) data provenance; and (3) data governance. Fitness for purpose comprises (1) data reliability items, ie, how accurate and complete the estimates are for answering the question at hand and (2) data relevance items, which assess how well the data are suited to answer the particular question from a decision-making perspective. The report includes a checklist specific to EHR data reporting: the ISPOR SUITABILITY Checklist. It also provides recommendations for HTA agencies and policy makers to improve the use of EHR-derived data over time. The report concludes with a discussion of limitations and future directions in the field, including the potential impact from the substantial and rapid advances in the diffusion and capabilities of large language models and generative artificial intelligence. The report's immediate audiences are HTA evidence developers and users. We anticipate that it will also be useful to other stakeholders, particularly regulators and manufacturers, in the future.

          Related collections

          Author and article information

          Journal
          Value Health
          Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
          Elsevier BV
          1524-4733
          1098-3015
          Jun 2024
          : 27
          : 6
          Affiliations
          [1 ] Office of the Director, National Institutes of Health, Bethesda, MD, USA. Electronic address: rachael.fleurence@nih.gov.
          [2 ] Erasmus School of Health & Policy Management, Erasmus University, Rotterdam, The Netherlands.
          [3 ] Flatiron Health, New York, NY, USA.
          [4 ] Duke University, Durham, NC, USA.
          [5 ] Clalit Health Services, Tel-Aviv, Israel.
          [6 ] Yale School of Medicine, Yale University, New Haven, CT, USA.
          [7 ] Janssen Research and Development, Titusville, NJ, USA.
          [8 ] Centre for Guidelines, National Institute for Health and Care Excellence, Manchester or London, England, UK.
          [9 ] National Pharmaceutical Council, Washington, DC, USA.
          [10 ] Public Health and Healthcare Division, Institut National du Cancer, Boulogne-Billancourt, France.
          [11 ] Health Technology Assessment and Health Economics Department, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
          [12 ] Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, WA, USA. Electronic address: sramsey@fredhutch.org.
          Article
          NIHMS1978932 S1098-3015(24)00069-X
          10.1016/j.jval.2024.01.019
          11182651
          38871437
          b9c9d69b-6186-437a-ac72-7a928c850a11
          History

          real-world data,data quality,real-world evidence,health technology assessment,electronic health records

          Comments

          Comment on this article